Biotechnology
-
Business
Patients regain weight after stopping Eli Lilly’s Zepbound, study says
[ad_1] Eli Lilly’s drug tirzepatide was approved for weight loss by the FDA. Courtesy of Eli Lilly Patients who took…
Read More » -
Health News
Cigna shares jump on reports of abandoned Humana buyout, plans for $10 billion stock buyback
[ad_1] Sopa Images | Lightrocket | Getty Images Shares of Cigna jumped Monday following reports that the health-care giant has…
Read More » -
Pics News
Occidental Petroleum to buy Permian producer CrownRock for $12 billion, raise dividend
[ad_1] Occidental Petroleum Jay L. Clendenin | Los Angeles Times | Getty Images Occidental Petroleum on Monday agreed to buy…
Read More » -
Health News
Biden administration asserts power to seize drug patents in move to slash high prices
[ad_1] President Joe Biden speaks about protecting Social Security, Medicare, and lowering prescription drug costs, during a visit to OB…
Read More » -
Business
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
[ad_1] A sign stands outside a Abbvie facility in Cambridge, Massachusetts, May 20, 2021. Brian Snyder | Reuters AbbVie on…
Read More » -
Health News
CVS to change how it prices prescription drugs with new pharmacy reimbursement model
[ad_1] A sign outside a CVS Health store in Miami, Aug. 1, 2023. Joe Raedle | Getty Images CVS Health…
Read More » -
Business
Free ChatGPT may incorrectly answer drug questions, study says
[ad_1] Harun Ozalp | Anadolu | Getty Images The free version of ChatGPT may provide inaccurate or incomplete responses —…
Read More » -
Health News
Roche enters obesity market with Carmot takeover but drugs may not be available until 2030
[ad_1] BRAZIL – 2021/11/26: In this photo illustration a F. HoffmannLa Roche AG logo is seen on a screen and…
Read More » -
Business
Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
[ad_1] Sopa Images | Lightrocket | Getty Images Pfizer’s twice-daily version of its experimental weight loss pill has now joined…
Read More » -
Business
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
[ad_1] Pfizer on Friday said it would stop developing the twice-daily version of its experimental weight loss pill after obese…
Read More »